Results 181 to 190 of about 23,251 (254)

Epidemiology of chronic lymphocytic leukaemia in Germany: A retrospective analysis of administrative claims data. [PDF]

open access: yesAnn Hematol
Maqhuzu PN   +8 more
europepmc   +1 more source

A Therapy‐Related ETV6::IL3 Translocation Defines a Presently Unclassified Myeloid Neoplasm With Eosinophilia

open access: yes
European Journal of Haematology, EarlyView.
Nili Modi   +2 more
wiley   +1 more source

Optimization of Leukocytic Flags in the Sysmex‐XN Series With the Help of Flow Cytometric Differential (FlowDiff) Can Significantly Optimize Laboratory Efficiency

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Objectives The aim of this study was to adjust the default white blood cell (WBC) differential count flag settings on the Sysmex XN‐9100 haematology analyser to reduce unnecessary additional leukocyte differential counts without compromising diagnostic sensitivity.
Ninna Hahn Tougaard   +4 more
wiley   +1 more source

SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor. [PDF]

open access: yesBlood Res
García-Muñoz R   +17 more
europepmc   +1 more source

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Despite pre‐emptive treatment (PeT), cytomegalovirus (CMV) disease and reactivation remain a clinical concern. In Australia and New Zealand (ANZ), variability exists in the management of CMV for haematopoietic stem cell transplantation (HSCT) recipients.
Andrea Henden   +13 more
wiley   +1 more source

A pilot randomized trial of supervised resistance training plus home-based activity in chronic lymphocytic leukaemia patients. [PDF]

open access: yesSci Rep
Sánchez-González JL   +13 more
europepmc   +1 more source

AustrAIHANZ – consensus guidelines on the investigation and management of autoimmune haemolytic anaemia in Australia and New Zealand

open access: yesInternal Medicine Journal, EarlyView.
Abstract Autoimmune haemolytic anaemia is a rare immune‐mediated disorder leading to accelerated red cell destruction and anaemia. There is considerable clinical heterogeneity, with some patients barely requiring intervention, while others experience fulminant haemolysis and experience mortality rates as high as 30% with severe anaemia and end‐organ ...
Philip Choi   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy